Surveys / Trackers / ATUs

The precision medicine market is dynamic, and technological and clinical disruption can cause it to pivot on a dime. Track your markets closely, distinguish signal from noise, and respond accordingly.

Our Experts

Pranay Madan

Andrew Aijian

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

View

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Research Tools

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

View

No items found.

Clinical Diagnostics

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

View

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

View

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch